GNS Healthcare Blog

GNS Healthcare Primary Blog

By December 31, 1969

GNS Healthcare Blog

3 Ways Machine Learning is Transforming Drug Development

A recent study revealed that nearly half of all pipeline compounds and close to three quarters of oncology compounds are utilizing biomarker data during the drug development process. The same report indicated that investment in biomarker identification by biopharma has doubled over the past five years and is forecasted to increase over the next half decade. [1] 

Biopharma’s increasing reliance on molecular data (most commonly genomic and proteomic) and the identification of specific biomarkers in the drug development process should not be surprising. Healthcare is transitioning to...

Read More

The Data Analytics Pyramid – Climbing to Optimization & Inference

The availability of data combined with the power of Artificial Intelligence (AI) is causing disruption and raising questions across a number of industries, including healthcare. The electronic medical record has provided digitized health information. Genomic data is now working its way into datasets. There have been impactful innovations in the areas of targeted intervention, drug and device development, software applications, population health approaches, collaboration among healthcare stakeholders and, precision medicine.

Read More

How AI is Replacing Prediction with Discovery Using Data

Hardly a day goes by without someone publishing an article on how artificial intelligence (AI) is revolutionizing the healthcare industry. No doubt AI is impacting multiple areas of the healthcare landscape from biopharma to health systems, to heath plans to patients.

One recent survey reported that 90 percent of pharma companies believe that AI is critical to their success.[1] Another report has 42 percent of healthcare system leaders saying they have or are planning to add AI as a tool for disease management.[2] Some even suggest AI will eventually replace physicians when diagnosing...

Read More

A Powerful Partnership: Artificial Intelligence and Longitudinal Data To Better Understand Multiple Myeloma

More than 30,000 people a year are diagnosed with multiple myeloma in the United States, making it the second most common type of blood cancer. Researchers have yet to find a cure, in part due to the diverse ways the disease manifests itself, but recent advances in cancer research have made it a treatable disease.

The availability of genomic data and power of artificial intelligence is driving more progress in the understanding of multiple myeloma.  Causal machine learning (causal ML) – a powerful form of artificial intelligence – has the ability to reduce the time to study disease and...

Read More

3 Ways Causal Machine Learning is Accelerating the Speed of Discovery in Health Care

Imagine if we could approach healthcare with the precision that retailers like Amazon and Netflix use to reach their customers. Imagine if we could grasp the holy grail of precision medicine and harness the ability to match patients with the specific treatment or intervention that is most effective for them as individuals.

How can we scale precision medicine so that every patient is provided with a personally optimized treatment plan? How can we turn data into models of disease progression and drug response, so we can discover novel biomarkers and accelerate drug discovery and development?

Read More

5 Challenges to Applying AI and Machine Learning in Healthcare

While artificial intelligence and machine learning technologies hold plenty of promise in helping to improve patient outcomes and lower costs in health care, making effective use of these technologies requires expertise and experience in handling massive data sets and the tools that extract the right information to answer healthcare’s most difficult questions.

Julie Slezak, EVP of Clinical Analytics at GNS, highlights the key stumbling blocks she sees most often and how to overcome them. Following are five key challenges. Consider this a giant heads-up to anyone employing artificial...

Read More

Why Causal Learning is a Superpower for Healthcare

Most people have never heard of causal learning, but the concept is an important one for the future of healthcare because it holds the key to understanding and fighting disease and improving outcomes. However, to understand how and why causality is so important in the fight for better healthcare, we have to first understand machine learning.

You may be familiar with the term “artificial intelligence”, which is a broader umbrella term that machine learning falls within. An article in Xconomy published earlier this year goes into detail on artificial intelligence (AI) and starts by talking...

Read More

Interview with Iya Khalil, Co-founder and CCO of GNS Healthcare

Now it’s time to introduce you to Iya Khalil, who co-founded GNS Healthcare with Colin Hill and serves as the company’s Chief Commercial Officer. When I sat down to talk with Iya, I wanted to get her insights into the company’s work and how it was going to bring its’ industry leading capabilities to more businesses and situations. I also wanted to know more about what the company is doing to identify and fight disease. She was able to help me understand how GNS is working with partners to improve the application of GNS’ solutions and the important work that remains to be accomplished. Now...

Read More

Interview with Colin Hill, CEO and Co-founder of GNS Healthcare

As we’re getting the ball rolling with our new blog, we agreed that there couldn’t be a better way to kick things off than with an interview with GNS Healthcare CEO, Chairman, and co-founder Colin Hill.  So when I had the chance to sit down for a discussion with Colin, what I wanted to know was what was the vision that convinced him to found GNS seventeen years ago and does that mission still hold true today.  What I found is that he has been driven by one seemingly simple question: What needs to be discovered and uncovered to stop disease and its progression?  He’s had a clear vision...

Read More

Welcome to the GNS Healthcare Blog

Our blog will be a forum for discussion – to tackle important issues in precision medicine and focus on how machine learning and artificial intelligence are being applied to improve health outcomes and lower the total cost of care. We’ll discuss topics like healthcare’s matching problem and how big ‘patient’ data can be used to discover which health interventions work for which patients. We’re excited to host this conversation.

While we don’t develop the drugs, or sell the health insurance plans, or treat patients, we work closely with health plans, biopharmaceutical companies, health...

Read More

Subscribe to the GNS Blog

Recent Posts:

Twitter